Literature DB >> 15466244

Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity.

Masaaki Miyata1, Aki Tozawa, Hijiri Otsuka, Toshifumi Nakamura, Kiyoshi Nagata, Frank J Gonzalez, Yasushi Yamazoe.   

Abstract

Mice lacking the farnesoid X receptor (FXR) involved in the maintenance of hepatic bile acid levels are highly sensitive to cholic acid-induced liver toxicity. Serum aspartate aminotransferase (AST) activity was elevated 15.7-fold after feeding a 0.25% cholic acid diet, whereas only slight increases in serum AST (1.7- and 2.5-fold) were observed in wild-type mice fed 0.25 and 1% cholic acid diet, respectively. Bile salt export pump mRNA and protein levels were increased in wild-type mice fed 1% cholic acid diet (2.1- and 3.0-fold) but were decreased in FXR-null mice fed 0.25% cholic acid diet. The bile acid output rate was 2.0- and 3.7-fold higher after feeding of 0.25 and 1.0% cholic acid diet in wild-type mice, respectively. On the other hand, no significant increase in bile acid output rate was observed in FXR-null mice fed 0.25% cholic acid diet in contrast to a significant decrease observed in mice fed a 1.0% cholic acid diet in spite of the markedly higher levels of hepatic tauro-conjugated bile acids. Unconjugated cholic acid was not detected in the bile of wild-type mice fed a control diet, but it was readily detected in wild-type mice fed 1% cholic acid diet. The ratio of biliary unconjugated cholic acid to total cholic acid (unconjugated cholic acid and tauro-conjugated cholic acid) reached 30% under conditions of hepatic taurine depletion. These results suggest that the cholic acid-induced enhancement of canalicular bile acid output rates and excretion of unconjugated bile acids are involved in adaptive responses for prevention of cholic acid-induced toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466244     DOI: 10.1124/jpet.104.076158

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Naoki Tanaka; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

2.  A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis.

Authors:  Xiu-Qi Chen; Lin-Lin Wang; Qing-Wen Shan; Qing Tang; Ya-Nan Deng; Shu-Jun Lian; Xiang Yun
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

Review 3.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

4.  Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.

Authors:  Tao Wang; Zhi-xing Zhou; Li-xin Sun; Xia Li; Zhi-meng Xu; Mi Chen; Guo-lin Zhao; Zhen-zhou Jiang; Lu-yong Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-11-24       Impact factor: 6.150

5.  Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.

Authors:  Masaaki Miyata; Yoshiki Matsuda; Masahiro Nomoto; Yuki Takamatsu; Nozomi Sato; Mayumi Hamatsu; Paul A Dawson; Frank J Gonzalez; Yasushi Yamazoe
Journal:  Drug Metab Dispos       Date:  2008-11-06       Impact factor: 3.922

6.  Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.

Authors:  Yue J Cui; Lauren M Aleksunes; Yuji Tanaka; Michael J Goedken; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2009-04-30       Impact factor: 4.849

7.  Cysteine sulfinic acid decarboxylase regulation: A role for farnesoid X receptor and small heterodimer partner in murine hepatic taurine metabolism.

Authors:  Thomas A Kerr; Yuri Matsumoto; Hitoshi Matsumoto; Yan Xie; Lawrence L Hirschberger; Martha H Stipanuk; Sayeepriyadarshini Anakk; David D Moore; Mitsuhiro Watanabe; Susan Kennedy; Nicholas O Davidson
Journal:  Hepatol Res       Date:  2013-10-18       Impact factor: 4.288

8.  Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice.

Authors:  Toshinori Kamisako; Yuji Tanaka; Yoshizumi Kishino; Takanori Ikeda; Kazuo Yamamoto; Shiori Masuda; Hiroshi Ogawa
Journal:  J Clin Biochem Nutr       Date:  2014-02-14       Impact factor: 3.114

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.